The combination of the antitumoural pyridyl cyanoguanidine CHS 828 and etoposide in vitro–from cytotoxic synergy to complete inhibition of apoptosis

Por Martinsson, P, Ekelund, S, Nygren, P, Larsson, R
Publicado em 2002

Reciprocal inhibition during the tonic stretch reflex in the decerebrate cat.

Por Fu, T C, Hultborn, H, Larsson, R, Lundberg, A
Publicado em 1978

Differential anti-inflammatory and anti-oxidative effects of dexamethasone and N-acetylcysteine in endotoxin-induced lung inflammation

Por Rocksén, D, Lilliehöök, B, Larsson, R, Johansson, T, Bucht, A
Publicado em 2000

Comparison of the cytotoxic activity of melphalan with L-prolyl-m-L-sarcolysyl-L-p-fluorophenylalanine in human tumour cell lines and primary cultures of tumour cells from patients...

Por Larsson, R., Dhar, S., Ehrsson, H., Nygren, P., Lewensohn, R.
Publicado em 1998

Replication of patient isolates of human immunodeficiency virus type 1 in T cells: a spectrum of rates and efficiencies of entry.

Por Fernandez-Larsson, R, Srivastava, K K, Lu, S, Robinson, H L
Publicado em 1992

In vitro testing of chemotherapeutic drug combinations in acute myelocytic leukaemia using the fluorometric microculture cytotoxicity assay (FMCA).

Por Larsson, R., Fridborg, H., Kristensen, J., Sundström, C., Nygren, P.
Publicado em 1993

Doxorubicin selected multidrug-resistant small cell lung cancer cell lines characterised by elevated cytoplasmic Ca2+ and resistance modulation by verapamil in absence of P-glycopr...

Por Nygren, P., Larsson, R., Gruber, A., Peterson, C., Bergh, J.
Publicado em 1991

Molecular analysis of the inhibitory effect of phosphorylated ribavirin on the vesicular stomatitis virus in vitro polymerase reaction.

Por Fernandez-Larsson, R, O'Connell, K, Koumans, E, Patterson, J L
Publicado em 1989

Anti-cancer drug characterisation using a human cell line panel representing defined types of drug resistance.

Por Dhar, S., Nygren, P., Csoka, K., Botling, J., Nilsson, K., Larsson, R.
Publicado em 1996

Membranoproliferative Glomerulonephritis and Inflammatory Pseudotumour of the Spleen

Por Hadimeri, U., Hultman, P., Larsson, R., Melander, S., Mölne, J., Hadimeri, H.
Publicado em 2013

Human immunodeficiency virus type 1 NL4-3 replication in four T-cell lines: rate and efficiency of entry, a major determinant of permissiveness.

Por Srivastava, K K, Fernandez-Larsson, R, Zinkus, D M, Robinson, H L
Publicado em 1991

The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function.

Por Larsson, R, Erlanson, P, Bodemar, G, Walan, A, Bertler, A, Fransson, L, Norlander, B
Publicado em 1982

Cytotoxic activity of topotecan in human tumour cell lines and primary cultures of human tumour cells from patients.

Por Jonsson, E., Fridborg, H., Csóka, K., Dhar, S., Sundström, C., Nygren, P., Larsson, R.
Publicado em 1997

In vitro discovery of promising anti-cancer drug combinations using iterative maximisation of a therapeutic index

Por Kashif, M., Andersson, C., Hassan, S., Karlsson, H., Senkowski, W., Fryknäs, M., Nygren, P., Larsson, R., Gustafsson, M.G.
Publicado no Sci Rep (2015)

Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia

Por Eriksson, A, Österroos, A, Hassan, S, Gullbo, J, Rickardson, L, Jarvius, M, Nygren, P, Fryknäs, M, Höglund, M, Larsson, R
Publicado no Blood Cancer J (2015)

Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles

Por Rickardson, L, Fryknäs, M, Dhar, S, Lövborg, H, Gullbo, J, Rydåker, M, Nygren, P, Gustafsson, M G, Larsson, R, Isaksson, A
Publicado em 2005

The novel tyrosine kinase inhibitor AKN-028 has significant antileukemic activity in cell lines and primary cultures of acute myeloid leukemia

Por Eriksson, A, Hermanson, M, Wickström, M, Lindhagen, E, Ekholm, C, Jenmalm Jensen, A, Löthgren, A, Lehmann, F, Larsson, R, Parrow, V, Höglund, M
Publicado em 2012